TMEM37 and infection: The SA pathway, triggered mainly by biotrophic pathogens, is involved in systemic acquired resistance (SAR), which induces the expression of the PR1, PR2, and PR5 genes and prevents the spread of infection to healthy tissues [2], whereas the JA pathway, mainly activated by necrotrophic pathogens, provides local acquired resistance (LAR) through the upregulation of PR3, PR4, and PR12 genes [2].